Publication | Open Access
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial
107
Citations
36
References
2014
Year
Norwegian Research Council GLOBVAC Program and Bionor Pharma ASA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1